Effectiveness of valproate on delirium and/or aggressive behavior in demented patients: A practical pilot study

References

• Rabins P V., Mace N L., Lucas MJ. The impact of dementia on the family. JAMA 1982; 248: 333–5
   PubMed Web of Science ®Google Scholar
• Nygaard HA. Strain on caregivers of demented elderly people living at home. Scand J Prim Health Care 1988; 6: 33–7
   PubMedGoogle Scholar
• Horiguchi J, Sukegawa T, Inami Y. Survey of the living conditions and psychosomatic states of the elderly people in Japan who receive home help. Psychiatry Clin Neurosci 1996; 50: 247–50
   PubMed Web of Science ®Google Scholar
• Aarsland D. Aggressive behavior in dementia and its pharmacological treatment: a review. Nord J Psychiatry 1995; 49: 111–8
   Web of Science ®Google Scholar
• Nyth A L., Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 1990; 157: 894–901
   PubMed Web of Science ®Google Scholar
• Schneider L S., Pollock VE. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38: 553–63
   PubMed Web of Science ®Google Scholar
• Schneider L S., Sobin PB. Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia. Psychopharmacol Bull 1992; 28: 71–9
   PubMedGoogle Scholar
• Schneider LS. Efficacy of treatment for geropsychiatric patients with severe mental illness. Psychopharmacol Bull 1993; 29: 501–24
   PubMedGoogle Scholar
• Pourcher E, Filteau M J., Bouchard RH, et al. Efficacy of the combination of buspirone and carbamazepine in early posttraumatic delirium. Am J Psychiatry 1994; 151: 150–1
   PubMed Web of Science ®Google Scholar
• Hillbom M, Tokola R, Kuusela V, et al. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol (AGG) 1989; 6: 223–6
   PubMed Web of Science ®Google Scholar
• Marin D B., Greenwald BS. Carbamazepine for aggressive agitation in demented patients during nursing care. Am J Psychiatry 1989; 146: 805
   PubMed Web of Science ®Google Scholar
• Trzepacz P T., Baker R W., Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988; 23: 89–97
   PubMed Web of Science ®Google Scholar
• Gottfries C G., Brane B, Steen G. A new rating scale for dementia syndromes. Arch Geront Geriatr 1982; 1: 311–30
   PubMedGoogle Scholar
• Patel V, Hope T. Aggressive behavior in elderly people with dementia: a review. Int J Geriatr Psychiatry 1993; 8: 457–72
   Web of Science ®Google Scholar
• Greist JH. Current use of carbamazepine and other anticonvulsants as lithium alternatives in bipolar disorders. Int Clin Psychopharmacol 1990; 5: 15–26
   Web of Science ®Google Scholar
• Small JG. Anticonvulsants in affective disorders. Psychopharmacol Bull 1990; 26: 25–36
   PubMedGoogle Scholar
• Pope H G., McEIroy S L., Keck PE, et al. Valproate in the treatment of acute mania. Arch Gen Psychiatry 1991; 48: 62–8
   PubMed Web of Science ®Google Scholar
• Calabrese J R., Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990; 147: 431–4
   PubMed Web of Science ®Google Scholar
• Schneider L S., Pollack VE. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38: 553–63
   PubMed Web of Science ®Google Scholar
• Fish DN. Treatment of delirium in the critically ill patients. Clin Pharmacol 1991; 10: 456–66
   PubMedGoogle Scholar
• Gleason R, Schneider LS. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. J Clin Psychiatry 1990; 51: 115–8
   PubMed Web of Science ®Google Scholar
• Yodofsky S, Williams D, Gorman J. Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndromes. Am J Psychiatry 1981; 138: 218–20
   PubMed Web of Science ®Google Scholar
• Weiler P G., Mungas D, Bemick C. Propranolol for the treatment of disruptive behavior in senile dementia. J Geriatr Psychiatry Neurol 1988; 1: 226–30
   PubMedGoogle Scholar
• Havens W W., Cole CJ. Successful treatment of dementia with delirium. J Clin Psychopharmacol 2 1982; 71–2
   Google Scholar
• Randels P M., Marco L A., Ford DJ, et al. Lithium and lecithin treatment in Alzheimer's disease: A pilot study. J Clin Psychiatry 1984; 6: 139–47
   Google Scholar
• Aarsland D. Aggressive behavior in dementia and its pharmacological treatment: a review. Nord J Psychiatry 1995; 49: 111–8
   Web of Science ®Google Scholar
• Colenda CC. Buspirone in treatment of agitated dementia patient. Lancet 1988; ii: 1169
   Google Scholar
• Schneider L S., Pollack V E., Zemansky MF, et al. A pilot study of low dose 1-deprenyl in Alzheimer's disease. J Geriatr Psychiatry 1991; 4: 143–8
   Google Scholar
• Valzelli L. Psychobiology of aggression and violence. Raven Press, New York 1981
   Google Scholar
• Coccaro EF. Central serotonin and impulsive aggression. Br J Psychiatry 1989; 155: 52–62
   Web of Science ®Google Scholar
• Meltzer H Y., Lowy MT. The serotonin hypothesis of depression. Psychopharmacology: The Third Generation of Progress, HY. Meltzer. Raven Press, New York 1987; 513–26
   Google Scholar
• Benkelfut C, Murphy D L., Zohar J, et al. Clomipramine in obsessive-compulsive disorder: further evidence for a serotonergic mechanism of action. Arch Gen Psychiatry 1989; 46: 23–8
   PubMed Web of Science ®Google Scholar
• Soubrie P. Neurones sérotoninergiques et comportement. J Pharmacologie 1986; 17: 107–12
   PubMedGoogle Scholar
• Roy A, Linnoila M. Suicidal behavior, impulsiveness and serotonin. Acta Psychiatr Scand 1988; 78: 529–35
   PubMed Web of Science ®Google Scholar
• Virkkunen M, Dejong J, Bartko J, et al. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. Arch Gen Psychiatry 1989; 46: 600–3
   PubMed Web of Science ®Google Scholar
• McElroy S L., Pope H G., Hudson JI, et al. Kleptomania: a report of 20 cases. Am J Psychiatry 1991; 148: 652–7
   PubMed Web of Science ®Google Scholar
• Florence L, Florence P, Henri P. Behavioral effects of trazodone in Alzheimer's disease. J Clin Psychiatry 1994; 55: 536–8
   PubMed Web of Science ®Google Scholar
• Green A R., Johnson O, Mountford JA, et al. Some anticonvulsant drugs alter monoamine-mediated behavior in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy. Br J Pharmacol 1985; 84: 337–46
   PubMed Web of Science ®Google Scholar
• Elphick M, Anderson S MP, Hallis KF, et al. Effects of carbamazepine on 5-hydroxytryptamine function in rodents. Psychopharmacol Berl 1990; 100: 49–53
   PubMed Web of Science ®Google Scholar